Design, implement and maintain a range of cost recovery arrangements to support affordable health care and ensure services provided to commercial entities are consistent with the Australian Government Charging Framework.
The Government will provide $29.5 million over 4 years from 2023-24 to design, implement and maintain a range of cost recovery arrangements to support affordable health care and ensure services provided to commercial entities are consistent with the Australian Government Charging Framework. Funding includes: * $13.4 million over 4 years from 2023-24 (and $3.4 million ongoing) to revise cost recovery arrangements relating to the Pharmaceutical Benefits Scheme, including implementing a new cost recovery scheme for stockholding assessments and funding for assessment of Pharmaceutical Benefits Advisory Committee applications * $11.4 million over 4 years from 2023-24 (and $2.9 million ongoing) to fund enhanced services to the medical device industry under new arrangements relating to the Prostheses List. These costs will be partially offset from increased revenue of $9.3 million over 4 years ($3.3 million ongoing) recovered from existing and new charges for services to the industry * $3.0 million in 2023-24 to implement cost recovery arrangements for the Medicinal Cannabis Program, including $2.3 million in capital funding to update the operating systems of the Office of Drug Control Health and Aged Care | * $1.2 million over two years from 2023-24 to design and develop cost recovery arrangements for the Medical Services Advisory Committee to support an efficient Medicare Benefits Schedule * $0.6 million over two years from 2023-24 to design and develop cost recovery arrangements for the Stoma Appliance Scheme to support ostomates to access subsidised stoma products. The cost of this measure will be partially met from within the existing resourcing of the Department of Health and Aged Care.